Next Article in Journal
Bothnian Palmoplantar Keratoderma: Further Delineation of the Associated Phenotype
Next Article in Special Issue
Polymorphisms in COMT and OPRM1 Collectively Contribute to Chronic Shoulder Pain and Disability in South African Breast Cancer Survivors’
Previous Article in Journal
Congenital Defects in a Patient Carrying a Novel Homozygous AEBP1 Variant: Further Expansion of the Phenotypic Spectrum of Ehlers–Danlos Syndrome Classical-like Type 2?
Previous Article in Special Issue
Short-Term Exposure to Ciprofloxacin Reduces Proteoglycan Loss in Tendon Explants
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Genes
Volume 13
Issue 12
10.3390/genes13122359
genes-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Association of Variants within Types V and XI Collagen Genes with Knee Joint Laxity Measurements

by
Samantha Beckley
1,
Roopam Dey
2,
Shaun Stinton
3,
Willem van der Merwe
1,4,
Thomas Branch
3,
Alison V. September
1,
Mike Posthumus
1,5 and
Malcolm Collins
1,*
1
Health through Physical Activity, Lifestyle and Sport Research Centre (HPALS) and the International Federation of Sports Medicine (FIMS) International Collaborating Centre of Sports Medicine, Division of Physiological Sciences, Department of Human Biology, University of Cape Town, Cape Town 7700, South Africa
2
Division of Biomedical Engineering and Division of Orthopaedic Surgery, Faculty of Health Sciences, University of Cape Town, Cape Town 7700, South Africa
3
End Range of Motion Improvement, Atlanta, GA 30324, USA
4
Sports Science Orthopaedic Clinic, Sports Science Institute of South Africa, Cape Town 7700, South Africa
5
Sports Science Institute of South Africa, Cape Town 7700, South Africa
*
Author to whom correspondence should be addressed.
Genes 2022, 13(12), 2359; https://doi.org/10.3390/genes13122359
Submission received: 30 August 2022 / Revised: 16 November 2022 / Accepted: 8 December 2022 / Published: 14 December 2022
(This article belongs to the Special Issue Genetics and Epigenetics of Musculoskeletal Pathologies)
Browse Figures
Review Reports Versions Notes

Abstract

:
Joint laxity is a multifactorial phenotype with a heritable component. Mutations or common polymorphisms within the α1(V) (COL5A1), α1(XI) (COL11A1) and α2(XI) (COL11A2) collagen genes have been reported or proposed to associate with joint hypermobility, range of motion and/or genu recurvatum. The aim of this study was to investigate whether polymorphisms within these collagen-encoding genes are associated with measurements of knee joint laxity and computed ligament length changes within the non-dominant leg. One hundred and six healthy participants were assessed for genu recurvatum (knee hyperextension), anterior-posterior tibial translation, external-internal tibial rotation and ligament length changes during knee rotation of their non-dominant leg. Participants were genotyped for COL5A1 rs12722 (T/C), COL11A1 rs3753841 (C/T), COL11A1 rs1676486 (T/C) and COL11A2 rs1799907 (A/T). The genotype-genotype combination of any two or more of the four COL5A1 rs12722 CC, COL11A1 rs3753841 CC, COL11A1 rs1676486 TT and COL11A2 rs1799907 AA genotypes was associated with decreased active and passive knee hyperextension. These genotype-genotype combinations, including sex (male), increased age and decreased body mass collectively, also contributed to decreased passive knee hyperextension. These findings suggest that COL5A1, COL11A1 and COL11A2 gene-gene interactions are associated with knee hyperextension measurements of the non-dominant leg of healthy individuals.

1. Introduction

Joint laxity, which is a multifactorial trait with a heritable component, is defined as the measured movement constrained by the structure of its ligaments, shape of bones and joint congruency [1,2]. Symptomatic joint hypermobility is a common clinical feature of classic Ehlers-Danlos syndrome (EDS), which is often caused by mutations within the α1(V) collagen gene (COL5A1) [3]. Furthermore, it was previously proposed that COL5A1, which encodes the α(1) chain of type V collagen, is associated with hypermobility spectrum disorders [4] and, although joint hypermobility is not a clinical feature, multifocal fibromuscular dysplasia (FMDMF) [5]. Common genetic variants within the COL5A1 gene are also associated with several musculoskeletal soft tissue injuries [6], including anterior cruciate ligament (ACL) ruptures and other ligament injuries [7]. Interestingly, increased generalised joint hypermobility (GJH) and knee joint laxity are also intrinsic risk factors for ACL rupture [8].
COL5A1 variants have been associated, albeit not extensively, with nonpathological joint laxity [9]. Specifically, the CC genotype of the COL5A1 rs12722 T/C variant was associated with increased sit and reach range of motion, a measurement partially determined by joint laxity, in older healthy participants [10]. In addition, the rs12722 T allele was found to associate with increased genu recurvatum (knee hyperextension) and GJH in females [11].
Type XI collagen is a structural and functional homologue of type V collagen and its α(1)XI and α(2)XI chains are encoded by the α1(XI) (COL11A1) and α2(XI) (COL11A2) collagen genes, respectively [12]. Mutations within these genes cause Stickler Syndrome, which although not present in all cases, is also characterised by joint hypermobility, amongst other clinical features [13]. Pathogenic variants within these genes can also cause fibrochondrogenesis, nonsyndromic deafness, Marshall syndrome and/or otospondylomegaepiphyseal dysplasia (OSMED) [14]. Although the association with ACL rupture has not been investigated, variants within the domestic dog COL11A1 genes have been reported to be associated with cranial cruciate ligament ruptures (analogous to the ACL in humans) [15]. The COL11A1 rs3753841 T, COL11A1 rs1676486 C and/or COL11A2 rs1799907 T alleles are however associated with increased risk of other musculoskeletal soft tissue injuries [16,17]. Interestingly, these studies also reported that the COL11A1 and/or COL11A2 variants interacted with COL5A1 variants to associate with risk of injury [16,17].
Although to our knowledge no studies have specifically investigated the association of the type XI collagen gene variants with any joint laxity measurements, we propose that genetic variants within COL5A1, COL11A1 and/or COL11A2 associate with the spectrum of measurements ranging from symptomatic joint hypermobility to the normal inter-individual variations in joint laxity [11,18]. An increase in joint laxity is also believed to be associated with an increased length in joint restraints, including the ligaments [19]. Therefore, larger changes in the length of the knee stabilising ligaments, including the ACL, posterior cruciate ligament (PCL), medial collateral ligament (MCL) and lateral collateral ligament (LCL) [20], may result in increased knee joint laxity.
This study aimed to investigate whether the COL5A1 rs12722 C/T, COL11A1 rs3753841 T/C, COL11A1 rs1676486 C/T and/or COL11A2 rs1799907 A/T variants are associated independently or via gene-gene interactions with genu recurvatum, anterior-posterior tibial translation (displacement) or external-internal tibial rotation of the non-dominant leg. An additional aim of the study was to determine whether these collagen gene variants were significant contributors in multiple linear regression models of the knee joint laxity measurements, as well as any computed knee ligament length changes within the non-dominant leg.

2. Materials and Methods

2.1. Participants

One-hundred and six moderately active (at least 150 min of moderate intensity exercise per week), apparently healthy participants were recruited from nearby fitness centres within the greater Cape Town area, as well as through social media and word of mouth, between February 2016 and October 2018. Participants were required to have no history of spinal cord injury or any history of injury to the non-dominant lower limb. An additional 28 participants with a history of injury (14 knee and 4 ankle) or treatment (n = 9) to the non-dominant lower limb were also recruited and included with the 106 participants in a sub-analysis (n = 134). Prior to testing, all participants were required to sign an informed consent form. Questionnaires detailing personal particulars, sporting activities, as well as previous medical and injury history, were completed by all participants. Since this was a genetic study, all participants included in the study were of self-reported European ancestry to minimise the possible effect of population stratification. Leg dominance was also self-reported and for the purpose of this study, data from the non-dominant leg was reported. This study was approved by the Human Research Ethics Committee of the Faculty of Health Sciences within the University of Cape Town (HREC ref: 859/2015).
Sit and reach assessments were measured as previously described [10]. Since this study was investigating inherent genotype effects, participants were instructed to refrain from performing any warm-up exercises prior to testing. This modification was adopted due to unpublished observations that range of motion (ROM) responds to external stimuli such as a warm-up in an individualised manner (Miller C-J et al., personal communication). The test was repeated and the larger of the two measurements was recorded. The Beighton Score was used to assess GJH as previously described [2].

2.2. Knee Joint Laxity Assessments

Passive and active genu recurvatum were measured in degrees as previously described using a goniometer while the participants were in the supine position on a plinth with a bolster under both feet. Lower degree values indicated increased knee hyperextension. For the active measurement, participants were instructed to hyperextend their leg [21].
The KT-1000 (MEDmetric Corporation, San Diego, CA, USA) arthrometer was used to assess anterior and posterior tibial translation, relative to the femur, at 133 N while the knee was positioned at 30° flexion. Active displacement was measured while the participant raised their foot in a controlled manner. Maximum displacement was recorded after the tibia was manually displaced by the tester until the endpoint.
Tibial external-internal rotation was measured using the Robotic Knee Testing (RKT) device as previously described [22]. The resulting data were used to produce load deformation curves, where the curve was divided into three sections: external rotation, area of play and internal rotation, which were defined by the turning points of the curve. External and internal rotation refers to the amount of rotation which occurred between the respective outermost point of the curve and turning points. Slack describes the amount of rotation which occurred between the two turning points of the curve (in the area of play) [22]. Reliability of the genu recurvatum and the anterior-posterior knee laxity measurements are summarised (Supplementary Tables S1 and S2) and the reliability of the RKT measurements has previously been published [22].

2.3. Measuring Ligament Length Change

Absolute knee-stabilising ligament length changes were calculated from the RKT motion data. A previously validated musculoskeletal knee model with six degrees of freedom was used for this study [23]. The model was obtained from https://simtk.org/frs/?group_id=933 (accessed on 1 October 2019) and was visualised using OpenSim software (version 3.3) (Stanford University, Stanford, CA, USA). Flexion/extension, abduction/adduction, internal/external rotation and medial/lateral translation kinematic data obtained from the RKT testing were used in the model. Ligament length changes were determined from maximum external and internal rotation in four ligaments within the knee joint, separated into ten bundles. This included two anterior cruciate ligament bundles (aACL and pACL), two posterior cruciate ligament bundles (aPCL and pPCL), three medial collateral ligament bundles (aMCL, iMCL and pMCL), two deep layer bundles of MCL (aDMCL and pDMCL) and one lateral collateral ligament bundle (LCL). Absolute ligament length change was the difference between initial (at maximum external rotation) and final (maximum internal rotation) lengths of a ligament.

2.4. DNA Extraction and Genotyping

A 5 mL venous blood sample was collected from the forearm of participants and stored at −20 °C until DNA extraction. DNA was extracted as previously described and the DNA samples were stored at −20 °C [24]. DNA samples were genotyped for COL5A1 rs12722 (C/T) using PCR and restriction fragment length polymorphism analysis as previously described [24]. The rs12722 T allele and TT genotype frequencies within the European population are 44.5 and 21.0%, respectively (www.ensemble.org; accessed on 4 November 2022).
TaqMan™ Genotyping Assays (Applied Biosystems, Waltham, MA, USA) were used for genotyping the DNA samples for COL11A1 rs1676486 (T/C) and rs3753841 (C/T), as well as COL11A2 rs1799907 (A/T), using the QuantStudio® 3 Real-Time PCR System (Applied Biosystems) and Genotyping Application on the Thermo Fisher Cloud (https://apps.thermofisher.com/apps/spa/, (accessed on 4 November 2022)). All plates included negative controls containing no DNA as well as additional positive controls with known genotypes. All laboratory work was conducted at the Health through Physical Activity, Lifestyle and Sport Research Centre (HPALS) laboratories, Sports Science Institute of South Africa Building, Newlands, Cape Town. In the European population, the minor allele and genotype frequencies of rs3753841 is 38.8% C and 14.3% CC; rs1676486 is 17.0% T and 2.8% TT; and rs1799907 is 27.7% T and TT 8.9% (www.ensemble.org; accessed on 4 November 2022).
The TT and CT genotypes of COL5A1 rs12722 were combined for all analyses because of the previous association of the injury protective CC genotype with ROM measurements [10,25]. The genotype profile combinations used in all analyses for rs3753841 (T/C), rs1676486 (C/T) and rs1799907 (T/A) were based on the previous association of the rs3753841 T, rs1676486 C and rs1799907 T allele-allele interactions with increased risk of Achilles tendinopathy [16] and the independent association of the rs3753841 TT genotype and the rs3753841 T and rs1676486 C allele-allele interactions with increased risk of carpal tunnel syndrome [17]. Similar to the COL5A1 analysis, the COL11A1 and COL11A2 genotypes containing the allele associated with increased risk of musculoskeletal soft tissue injury were combined and compared to the protective CC, TT and AA genotypes for rs3753841, rs1676486 and rs1799907, respectively.

2.5. Statistical Analysis

The required sample size for this study was based on previously published research reporting the collagen genotype effects on knee joint laxity measurements [11]. The Shapiro-Wilk test was used to test for normality. Categorical data were compared using the Chi-squared or Fisher’s Exact tests. Unpaired t-test or one-way ANOVA were used for continuous normally distributed data, while Mann Whitney-U or Kruskal-Wallis tests were used for non-parametric data. Test for linear trend or Dunn’s multiple comparisons tests were used to compare groups.
Hardy-Weinberg Equilibrium was also calculated using R statistical software. The IBM SPSS Statistics software (version 25) or Prism (version 9.4.1) were used for all remaining statistical analyses. Significance was set at p < 0.05. Data were presented as mean and standard deviation if normally distributed, or as median and interquartile ranges (IQR) if not normally distributed.
Genotype scores were calculated as a proxy for genotype-genotype interactions and were based on the previous independent and/or collective association of COL5A1 (rs12722), COL11A1 (rs3753841 and rs1676486) and COL11A2 (rs1799907) with musculoskeletal soft tissue injuries [16,17,26]. Each of the reduced injury risk COL5A1 rs12722 CC, COL11A1 rs3753841 CC, COL11A1 rs1676486 TT and COL11A2 rs1799907 AA genotypes were given a score of 2, such that participants with none, one, two, three or all four of the associated reduced injury risk genotypes had a total score of 0, 2, 4 or 8, respectively (none of the participants had a genotype score of 8).
To explore which physical characteristics or genotypes were significant predictors of knee joint laxity measurements, multiple linear regression analyses using backward elimination were performed. Assumptions of linear regression were tested.

3. Results

3.1. General Characteristics

The average age, height, body mass and BMI of the participants were 27.5 ± 5.4 years, 174.7 ± 9.9 cm, 72.3 ± 12.6 kg and 23.6 ± 3.0 kg/m2, respectively. Fifty-eight (54.7%) were male, while 91 (85.9%) reported being right leg dominant and 59 (55.7%) reported taking part in flexibility training. All genetic variants were in Hardy-Weinberg Equilibrium and allele as well as genotype frequencies were similar to those reported for European populations (COL5A1 rs12722: p = 0.073, T allele = 56.2% and TT genotype = 26.9%; COL11A1 rs3753841 p = 0.838, C allele = 39.2% and CC genotype = 16.0%; COL11A1 rs1676486 p = 0.318, T allele = 17.9% and TT genotype = 4.7%; and COL11A2 rs1799907 p = 0.653, T allele = 32.2% and TT genotype = 11.5%).
There were no genotype effects for COL5A1 rs12722, COL11A1 rs3753841, COL11A1 rs1676486 or COL11A2 rs1799907 on the general characteristics of the participants, their flexibility training, Beighton scores or sit and reach measurements (Supplementary Tables S3 and S4). Similarly, there were no genotype effects for COL5A1 rs12722, COL11A1 rs3753841 or COL11A2 rs1799907 on any of the general characteristics when the subset of participants tested using the RKT device were analysed. COL11A1 rs1676486 could not be included in the sub-analysis because only three participants had the protective TT genotype (Supplementary Tables S5 and S6).

3.2. Association of Collagen Genotypes with Knee Laxity Measurements

There was a significant (p = 0.017) decrease in the average external rotation measurement of the COL5A1 rs12722 CC genotype group (4.6 ± 1.5°) compared to the combined TT and CT genotype group (5.6 ± 1.1°) (Supplementary Table S7). There were no other significant differences between the genu recurvatum, anterior-posterior tibial translation or external-internal tibial rotation measurements and the COL5A1 (rs12722), COL11A1 (rs3753841, rs1676486) or COL11A2 (rs1799907) genotype groups in the non-dominant leg (Supplementary Tables S7 and S8). Similar results were obtained when the 28 additional participants with a history of non-dominant lower limb injury and/or treatment were included in the analysis (Supplementary Tables S9–S12).
In order to investigate type V and XI collagen genotype interactions, genotype scores were calculated so that participants with none, any one, any two, any three or all four of the COL5A1 rs12722 CC, COL11A1 rs3753841 CC and/or rs1676486 TT and/or COL11A2 rs1799907 AA genotypes had genotype scores of 0, 2, 4, 6 and 8, respectively. None of the participants had all four genotypes (genotype score of 8). Genotype scores of 4 (n = 13) and 6 (n = 4) were combined for the analysis. There were no genotype score effects on the general characteristics of the participants, their flexibility training, Beighton scores or sit and reach measurements when all the participants or only the subset of participants tested using the RKT device were analysed (Supplementary Tables S13 and S14).
The average active genu recurvatum of the participants with a genotype score of 0 was lower (greater knee hyperextension) than that of participants with a genotype score of 4 or 6 (score 0: 173.4 ± 5.3°, n = 41; score 2 175.3 ± 6.1°, n = 44; score 4 or 6 176.7 ± 5.4°, n = 17; p for linear trend 0.029) (Figure 1A). Similarly, the median passive genu recurvatum of the 0 genotype score group was significantly lower (p = 0.048) that that of the 4 or 6 group [score 0: 176.0° (172.8°; 179.0°), n = 41; score 2: 177.0° (173.0°; 182.0°), n = 44; score 4 or 6: 179.0° (176.6°; 181.0°), n = 17] (Figure 1B). There were no genotype score effects on any of the anterior-posterior translation or external-internal rotation measurements of the non-dominant knee (Figure 2 and Supplementary Table S15). In support of this finding, there was a significant positive correlation between increase in genotype score and an increase in active (r = 0.245, p = 0.013) and passive (r = 0.217, p = 0.029) genu recurvatum of the non-dominant knee, but none of the other measurements. Similar results were obtained when the 28 additional participants with a history of non-dominant lower limb injury and/or treatment were included in the analysis (Supplementary Tables S16 and S17). Interestingly, 17.3% (n = 9), 10.3% (n = 6) and 5.0% (n = 1) of the participants with genotype scores of 0, 2 and 4/6, respectively, were able to extend their non-dominant knee beyond 10° (hyperextension) during the Beighton test.

3.3. Contribution of Collagen Genotype Score to the Multiple Linear Regression Models

The COL5A1, COL11A1 and COL11A2 genotype score, as well as age, sex and body mass were significant predictors of measurements of passive genu recurvatum, and the model explained 18% of the variance compared to 15% when genotype was not included in the model (Table 1). Specifically, the analysis showed that being a male, having a one unit increase in age (year), a one kg decrease in body mass and a genotype score of 4 or 6 was predicted to decrease passive knee hyperextension by 5.00°, 0.23°, 0.13° and 3.55°, respectively, when all of the other variables were held constant. The genotype score was however not considered to be a significant predictor of active genu recurvatum (Supplementary Table S18). Similar results were obtained when the 28 additional participants with a history of non-dominant lower limb injury and/or treatment were included in the analysis (Supplementary Table S19).

3.4. Ligament Length Change

There were no significant differences in knee ligament length changes between the COL5A1, COL11A1 and COL11A2 genotype score groups (Supplementary Table S20).

4. Discussion

The main novel finding of this study was that participants with any two or more of the COL5A1 rs12722 CC, COL11A1 rs3753841 CC, COL11A1 rs1676486 TT and COL11A2 rs1799907 AA genotypes were significantly associated with reduced passive and active knee hyperextension of the non-dominant leg. Furthermore, these genotype combinations were also found to predict measurements of only passive knee hyperextension in a multiple linear regression model, where the effect size of the overall model was considered to be medium [27]. Additionally, the external tibial rotation was significantly lower in the COL5A1 rs12722 CC genotype group. No other genetic associations were noted with any of the anterior-posterior tibial translation nor external-internal tibial rotation measurements.
The CC genotype of rs12722, which is located within the functional COL5A1 3′-UTR and is associated with increased mRNA degradation [28], was previously reported to be independently associated with increased sit and reach measurements in older, healthy participants of self-reported European ancestry [10], as well as with increased straight leg raise (SLR) measurements in young Asian college students [25]. This variant was however not associated with SLR measurements in Korean ballerinas [29] and Japanese athletes [30], as well as with whole body laxity [25]. Similar to previous studies, COL5A1 rs12722 was not independently associated with sit and reach measurements in the younger participants included in this study [10,29,30]. The COL5A1 rs12722 CC genotype was associated with increased extensible tendon structures for knee extensors, but not for plantar flexors [31], while the T allele was associated with greater measures of mechanical stiffness of the quadriceps muscle–tendon at moderate contraction levels [32]. It was however not associated with the volume, elastic modulus and Z of the patellar tendon [33]. Although not all studies have reported an association, several have reported an independent association of the COL5A1 rs12722 CC genotype and/or C allele with a reduced risk (protective effect) of musculoskeletal soft tissue injuries, predominately tendinopathy (reviewed in [26]).
Types V and XI collagen are both fibril-forming collagens that are required to work in a coordinated manner to regulate nucleation and assembly of the collagen fibril within the developing tendon and other tissues [12]. Both COL11A1 rs3753841 and rs1676486 are non-synonymous, resulting in substitutions of a leucine with a proline and a proline with a serine, respectively [34]. The rs1676486 T allele has also been reported to be associated with increased mRNA degradation [35]. The COL11A2 rs1799907 variant produces different isoforms of the α2(XI) chain within the terminal acidic domain, an important binding site for a number of other molecules. It has been suggested that this alteration may affect the deposition of other collagen molecules on the fibril [36]. Since several variants have been shown to regulate mRNA degradation of type V and XI collagen mRNA, Hay et al. (2013) have proposed that these variants result in altered levels of types V and XI collagen production [16].
Compared to COL5A1, the potential biological effects of the COL11A1 and COL11A2 variants investigated in this study on musculoskeletal tissue function and properties have, to our knowledge, not been investigated. The COL11A1 rs3753841 and/or COL11A2 rs1799907 variants have however been associated with lumbar disc herniation [37], limbus vertebra in gymnasts [38], lumbar spine stenosis [39], ossification of the posterior longitudinal ligament of the spine [36] and rheumatoid arthritis [40]. In addition, interactions between the COL11A1 rs3753841 T, COL11A1 rs1676486 C, COL11A2 rs1799907 T and/or COL5A1 rs7174644 AGGG alleles, the latter of which is also located within the functional COL5A1 3′-UTR, were previously reported to be associated with increased risk of Achilles tendinopathy in two populations [16] and carpal tunnel syndrome [17]. The reported combined association of the COL5A1 rs12722 CC, COL11A1 rs3753841 CC, COL11A1 rs1676486 TT and COL11A2 rs1799907 AA genotypes in this study aligns with the reports by several researchers that showed that reduced knee hyperextension is associated with a decreased risk of ACL rupture [41] and that the COL5A1 rs12722 T allele was associated with increased knee hyperextension in females [11]. Future research should therefore evaluate these and other variants within the type XI collagen genes and the possible collective interactions with the COL5A1 variants and their effect on musculoskeletal tissue function and properties.
While COL5A1, COL11A1 and COL11A2 genotype-genotype interactions were significantly associated with passive and active genu recurvatum, these genetic interactions only predicted passive genu recurvatum measurements. Passive range of motion measurements are more likely to represent underlying biological differences in musculoskeletal soft tissue mechanical properties when compared to active measurements, which may be additionally influenced by muscle size and strength. A limitation of the in-silico musculoskeletal knee model used to calculate ligament length changes (in OpenSim) was that certain subject-specific parameters could not be taken into account, such as bone geometry, joint space and joint capsule. The linear regression model presented in this study demonstrated the multifactorial nature of knee laxity as age, sex and body mass were all identified as predictors of genu recurvatum, but it also highlighted the contribution of specific genetic variants to knee laxity measurements. It is highly likely that the genetic contribution is polygenic. Since only four variants within three collagen genes were investigated in this study, future studies should investigate other genes involved in connective tissue biology. Moreover, the currently study had a relatively low sample size. Although associations were found, it is important that these associations are repeated in large cohorts. Since only a small number of participants included in this study tested positive for knee hyperextension, future research with a larger cohort may also investigate the association of these collagen genes within participants with symptomatic knee hyperextension and/or generalised joint hypermobility.
In conclusion, the findings of this study provide evidence supporting the role of variants within COL5A1, COL11A1 and COL11A2, together with physiological characteristics age, sex and body mass in collectively associating with measurements of laxity, specifically passive genu recurvatum.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/genes13122359/s1: Supplementary Table S1: The intraclass correlation coefficient (ICC), standard error of measurement (SEM) as well as the minimum detectable change at 90% confidence (MDC90) of genu recurvatum (passive and active) and anterior-posterior laxity (133 N anterior and posterior translation compliance index, active and maximum displacement) measurements in the non-dominant leg; Table S2: Descriptive data for the five trials of the reliability study for of genu recurvatum (passive and active) and anterior-posterior laxity (133 N anterior (Ant) and posterior (Post) translation (Trans), compliance index, active and maximum (Max) displacement) measurements in the non-dominant leg; Table S3: The COL5A1 rs12722 (T/C) genotype effects on the general characteristics, Beighton score and sit and reach measurements of participants with a history of an uninjured non-dominant leg; Table S4: The COL11A1 rs3753841 (T/C), rs1676486 (C/T) and COL11A2 rs1799907 (A/T) genotype effects on the general characteristics, Beighton score and sit and reach measurements of participants with a history of an uninjured non-dominant leg; Table S5: The COL5A1 rs12722 (T/C) genotype effects on the general characteristics, Beighton score and sit and reach measurements for the subset of participants with a history of an uninjured non-dominant leg measured on the Robotic Knee Testing (RKT) device; Table S6: The COL11A1 rs3753841 (T/C) and COL11A2 rs1799907 (A/T) genotype effects on the general characteristics, Beighton score and sit and reach measurements for the subset of participants with a history of an uninjured non-dominant leg measured on the Robotic Knee Testing (RKT) device; The COL5A1 rs12722 (T/C) genotype effects on the (i) passive and active genu recurvatum measurements, (ii) anterior (Ant) and posterior (Post) tibial translation, active and maximum (Max) displacement as well as compliance index measured using the KT-1000 arthrometer, and (iii) internal and external rotation, as well as slack measured using the Robotic Knee Testing (RKT) device of participants with a history of an uninjured non-dominant leg; Table S8: The COL11A1 rs3753841 (T/C), rs1676486 (C/T) and COL11A2 rs1799907 (A/T) genotype effects on the (i) passive and active genu recurvatum measurements, (ii) anterior (Ant) and posterior (Post) tibial translation, active and maximum (Max) displacement as well as compliance index measured using the KT-1000 arthrometer, and (iii) internal and external rotation, as well as slack measured using the Robotic Knee Testing (RKT) device of participants with a history of an uninjured non-dominant leg; Table S9: The COL5A1 rs12722 (T/C) genotype effects on the general characteristics, Beighton score and sit and reach measurements of participants with a history of an uninjured non-dominant leg, as well as those with a history of non-dominant lower limb injury and/or treatment; Table S10: The COL5A1 rs12722 (T/C) genotype effects on the (i) passive and active genu recurvatum measurements, and (ii) anterior (Ant) and posterior (Post) tibial translation, active and maximum (Max) displacement as well as compliance index measured using the KT-1000 arthrometer of participants with a history of an uninjured non-dominant leg, as well as those with a history of non-dominant lower limb injury and/or treatment; Table S11: The COL11A1 rs3753841 (T/C), rs1676486 (C/T) and COL11A2 rs1799907 (A/T) genotype effects on the general characteristics, Beighton score and sit and reach measurements of participants with a history of an uninjured non-dominant leg, as well as those with a history of non-dominant lower limb injury and/or treatment; Table S12: The COL11A1 rs3753841 (T/C), rs1676486 (C/T) and COL11A2 rs1799907 (A/T) genotype effects on the (i) passive and active genu recurvatum measurements, and (ii) anterior (Ant) and posterior (Post) tibial translation, active and maximum (Max) displacement as well as compliance index measured using the KT-1000 arthrometer of participants with a history of an uninjured non-dominant leg, as well as those with a history of non-dominant lower limb injury and/or treatment; Table S13: The COL5A1 rs12722 (T/C), COL11A1 rs3753841 (T/C), COL11A1 rs1676486 (T/C) and COL11A2 rs1799907 (A/T) genotype score effects on the general participant characteristics, Beighton score and sit and reach measurements; Table S14: The COL5A1 rs12722 (T/C), COL11A1 rs3753841 (T/C), COL11A1 rs1676486 (T/C) and COL11A2 rs1799907 (A/T) genotype score effects on the general participant characteristics, Beighton score and sit and reach measurements for the subset group of participants measured on the Robotic Knee Testing (RKT) device; Table S15: The COL5A1 rs12722 (T/C), COL11A1 rs3753841 (T/C), COL11A1 rs1676486 (T/C) and COL11A2 rs1799907 (A/T) genotype score effects on the (i) anterior (Ant) and posterior (Post) tibial translation, active and maximum (Max) displacement as well as compliance index measured using the KT-1000 arthrometer, and (ii) internal and external rotation, as well as slack measured using the Robotic Knee Testing (RKT) device of the participants’ non-dominant leg; Table S16: The COL5A1 rs12722 (T/C), COL11A1 rs3753841 (T/C), COL11A1 rs1676486 (T/C) and COL11A2 rs1799907 (A/T) genotype score effects on the general characteristics, Beighton score and sit and reach measurements of participants with a history of an uninjured non-dominant leg, as well as those with a history of non-dominant lower limb injury and/or treatment; Table S17: The COL5A1 rs12722 (T/C), COL11A1 rs3753841 (T/C), COL11A1 rs1676486 (T/C) and COL11A2 rs1799907 (A/T) genotype score effects on the (i) passive and active genu recurvatum measurements, and (ii) anterior (Ant) and posterior (Post) tibial translation, active and maximum (Max) displacement as well as compliance index measured using the KT-1000 arthrometer of participants with a history of an uninjured non-dominant leg, as well as those with a history of non-dominant lower limb injury and/or treatment; Table S18: Summary of multiple linear regression model for active genu recurvatum of participants with a history of an uninjured non-dominant leg; Table S19: Summary of multiple linear regression model for passive genu recurvatum of participants with a history of an uninjured non-dominant leg. as well as those with a history of non-dominant lower limb injury and/or treatment; Table S20: The COL5A1 rs12722 (T/C), COL11A1 rs3753841 (T/C), COL11A1 rs1676486 (T/C) and COL11A2 rs1799907 (A/T) genotype score effects on the absolute change in the length of the anterior bundle of the ACL (aACL), posterior bundle of the ACL (pACL), anterior bundle of the PCL (aPCL), posterior bundle of the PCL (pPCL), anterior bundle of the superficial layer of the MCL (aMCL), inferior bundle of the superficial layer of the MCL (iMCL), anterior bundle of the deep layer of the MCL (aDMCL), posterior bundle of the deep layer of the MCL (pDMCL), posterior bundle of the superficial layer of the MCL (pMCL) and the LCL of the non-dominant leg

Author Contributions

Conceptualization, M.P., W.v.d.M., S.S. and T.B.; methodology, S.B., M.C., A.V.S., R.D., M.P., W.v.d.M., S.S. and T.B.; participant recruitment and testing, S.B.; formal analysis, S.B., R.D. and M.C.; writing—original draft preparation, S.B.; writing—review and editing, M.C., M.P. and A.V.S.; supervision, M.P., M.C. and A.V.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors. Samantha Beckley was funded by the National Research Foundation (NRF) and the University of Cape Town (Duncan Baxter Scholarship and Postgraduate Publication Incentive Award from the Faculty of Health Sciences Research Committee).

Institutional Review Board Statement

This study was approved by the Human Research Ethics Committee of the Faculty of Health Sciences within the University of Cape Town, Cape Town, South African (HREC ref: 859/2015).

Informed Consent Statement

Written informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Not applicable.

Acknowledgments

The authors thank all of the participants for their time, Maia Lesosky for her statistical guidance as well as Chris Madden for his assistance with software programming and data analysis.

Conflicts of Interest

The robotic knee testing device (RKT) was provided by ErmiLLC. Shaun Stinton (Director of Research and Development), Thomas Branch (CEO) and Samantha Beckley (Clinical Research Manager) are employees at this company. Beckley was only employed after completion of this study. For the remaining authors, no conflicts of interest are declared.

References

  1. Cross, M. Clinical terminology for describing knee instability. Sport. Med. Arthrosc. Rev. 1996, 4, 313–318. [Google Scholar]
  2. Beighton, P.; Solomon, L.; Soskolne, C.L. Articular mobility in an African population. Ann. Rheum. Dis. 1973, 32, 413–418. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Malfait, F.; Wenstrup, R.J.; De Paepe, A. Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type. Genet. Med. 2010, 12, 597–605. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Grahame, R. Joint hypermobility and genetic collagen disorders: Are they related? Arch. Dis. Child. 1999, 80, 188–191. [Google Scholar] [CrossRef] [Green Version]
  5. Richer, J.; Hill, H.L.; Wang, Y.; Yang, M.-L.; Hunker, K.L.; Lane, J.; Blackburn, S.; Coleman, D.M.; Eliason, J.; Sillon, G.; et al. A Novel Recurrent COL5A1 Genetic Variant Is Associated With a Dysplasia-Associated Arterial Disease Exhibiting Dissections and Fibromuscular Dysplasia. Arter. Thromb. Vasc. Biol. 2020, 40, 2686–2699. [Google Scholar] [CrossRef]
  6. Ribbans, W.J.; September, A.V.; Collins, M. Tendon and Ligament Genetics: How Do They Contribute to Disease and Injury? A Narrative Review. Life 2022, 12, 663. [Google Scholar] [CrossRef]
  7. Alvarez-Romero, J. Genetic variants within the COL5A1 gene are associated with ligament injuries in physically active populations from Australia, South Africa, and Japan. Eur. J. Sport Sci. 2022, 1–10. [Google Scholar] [CrossRef]
  8. Shultz, S.J.; Schmitz, R.J.; Benjaminse, A.; Collins, M.; Ford, K.; Kulas, A.S. ACL Research Retreat VII: An Update on Anterior Cruciate Ligament Injury Risk Factor Identification, Screening, and Prevention. J. Athl. Train 2015, 50, 1076–1093. [Google Scholar] [CrossRef] [Green Version]
  9. Collins, M.; O’Connell, K.; Posthumus, M. Genetics of Musculoskeletal Exercise-Related Phenotypes. Med. Sport Sci. 2016, 61, 92–104. [Google Scholar]
  10. Brown, J.C.; Miller, C.-J.; Schwellnus, M.P.; Collins, M. Range of motion measurements diverge with increasing age for COL5A1 genotypes. Scand. J. Med. Sci. Sports 2011, 21, e266–e272. [Google Scholar] [CrossRef]
  11. Bell, R.D.; Shultz, S.J.; Wideman, L.; Henrich, V.C. Collagen gene variants previously associated with anterior cruciate ligament injury risk are also associated with joint laxity. Sport. Health 2012, 4, 312–318. [Google Scholar] [CrossRef] [PubMed]
  12. Bell, R.D.; Shultz, S.J.; Wideman, L.; Henrich, V.C. Regulation of collagen fibril nucleation and initial fibril assembly involves coordinate interactions with collagens V and XI in developing tendon. J. Biol. Chem. 2011, 286, 20455–20465. [Google Scholar]
  13. Acke, F.R. Novel pathogenic COL11A1/COL11A2 variants in Stickler syndrome detected by targeted NGS and exome sequencing. Mol. Genet. Metab. 2014, 113, 230–235. [Google Scholar] [CrossRef] [PubMed]
  14. Jobling, R.; D’Souza, R.; Baker, N.; Lara-Corrales, I.; Mendoza-Londono, R.; Dupuis, L.; Savarirayan, R.; Ala-Kokko, L.; Kannu, P. The collagenopathies: Review of clinical phenotypes and molecular correlations. Curr. Rheumatol. Rep. 2014, 16, 394. [Google Scholar] [CrossRef] [PubMed]
  15. Baird, A.E.G.; Carter, S.D.; Innes, J.F.; Ollier, W.E.; Short, A.D. Genetic basis of cranial cruciate ligament rupture (CCLR) in dogs. Connect. Tissue Res. 2014, 55, 275–281. [Google Scholar] [CrossRef]
  16. Hay, M.; Patricios, J.; Collins, R.; Branfield, A.; Cook, J.; Handley, C.J.; September, A.V.; Posthumus, M.; Collins, M. Association of type XI collagen genes with chronic Achilles tendinopathy in independent populations from South Africa and Australia. Br. J. Sports Med. 2013, 47, 569–574. [Google Scholar] [CrossRef] [Green Version]
  17. Dada, S.; Burger, M.C.; Massij, F.; de Wet, H.; Collins, M. Carpal tunnel syndrome: The role of collagen gene variants. Gene 2016, 587, 53–58. [Google Scholar] [CrossRef]
  18. Collins, M.; Posthumus, M. Type V collagen genotype and exercise-related phenotype relationships: A novel hypothesis. Exerc. Sport Sci. Rev. 2011, 39, 191–198. [Google Scholar] [CrossRef]
  19. Johnson, S.M.; Robinsonand, C.M. Shoulder instability in patients with joint hyperlaxity. J. Bone Jt. Surg. Am. 2010, 92, 1545–1557. [Google Scholar] [CrossRef]
  20. Clarke, H.D. Anatomy. In Insall & Scott Surgery of the Knee; Scott, W.N., Ed.; Elsevier: Philadelphia, PA, USA, 2018; pp. 2–49.e3. [Google Scholar]
  21. Shultz, S.J.; Nguyen, A.-D.; Levine, B.J. The Relationship Between Lower Extremity Alignment Characteristics and Anterior Knee Joint Laxity. Sport. Health 2009, 1, 54–60. [Google Scholar] [CrossRef]
  22. Beckley, S.; Stinton, S.; Lesosky, M.; September, A.; Collins, M.; Branch, T.; Posthumus, M. Reliability of a Robotic Knee Testing Tool to Assess Rotational Stability of the Knee Joint in Healthy Female and Male Volunteers. SportS Med. Open 2020, 6, 33. [Google Scholar] [CrossRef] [PubMed]
  23. Xu, H.; Bloswick, D.; Merryweather, A. An improved OpenSim gait model with multiple degrees of freedom knee joint and knee ligaments. Comput. Methods Biomech. Biomed. Eng. 2015, 18, 1217–1224. [Google Scholar] [CrossRef] [PubMed]
  24. Mokone, G.G.; Schwellnus, M.P.; Noakes, T.D.; Collins, M. The COL5A1 gene and Achilles tendon pathology. Scand. J. Med. Sci. Sport. 2006, 16, 19–26. [Google Scholar] [CrossRef] [PubMed]
  25. Lim, S.-T.; Kim, C.-S.; Kim, W.-N.; Min, S.-K. The COL5A1 genotype is associated with range of motion. J. Exerc. Nutr. Biochem. 2015, 19, 49–53. [Google Scholar] [CrossRef] [Green Version]
  26. Lv, Z.-T.; Gao, S.-T.; Cheng, P.; Liang, S.; Yu, S.-Y.; Yang, Q.; Chen, A.-M. Association between polymorphism rs12722 in COL5A1 and musculoskeletal soft tissue injuries: A systematic review and meta-analysis. Oncotarget 2018, 9, 15365–15374. [Google Scholar] [CrossRef] [Green Version]
  27. Cohen, J. Statistical Power Analysis for the Behavioral Sciences, 2nd ed.; Routledge: New York, NY, USA, 1988. [Google Scholar]
  28. Laguette, M.-J.; Abrahams, Y.; Prince, S.; Collins, M. Sequence variants within the 3′-UTR of the COL5A1 gene alters mRNA stability: Implications for musculoskeletal soft tissue injuries. Matrix Biol. 2011, 30, 338–345. [Google Scholar] [CrossRef]
  29. Kim, J.H.; Jung, E.S.; Kim, C.-H.; Youn, H.; Kim, H.R. Genetic associations of body composition, flexibility and injury risk with ACE, ACTN3 and COL5A1 polymorphisms in Korean ballerinas. J. Exerc. Nutr. Biochem. 2014, 18, 205–214. [Google Scholar] [CrossRef] [Green Version]
  30. Miyamoto-Mikami, E.; Miyamoto, N.; Kumagai, H.; Hirata, K.; Kikuchi, N.; Zempo, H.; Kimura, N.; Kamiya, N.; Kanehisa, H.; Naito, H.; et al. COL5A1 rs12722 polymorphism is not associated with passive muscle stiffness and sports-related muscle injury in Japanese athletes. BMC Med. Genet. 2019, 20, 192. [Google Scholar] [CrossRef] [Green Version]
  31. Kubo, K.; Yata, H.; Tsunoda, N. Effect of gene polymorphisms on the mechanical properties of human tendon structures. SpringerPlus 2013, 2, 343. [Google Scholar] [CrossRef] [Green Version]
  32. Kirk, E.A. Human COL5A1 polymorphisms and quadriceps muscle-tendon mechanical stiffness in vivo. Exp. Physiol. 2016, 101, 1581–1592. [Google Scholar] [CrossRef] [Green Version]
  33. Foster, B.P.; Morse, C.I.; Onambele, G.L.; Williams, A.G. Human COL5A1 rs12722 gene polymorphism and tendon properties in vivo in an asymptomatic population. Eur. J. Appl. Physiol. 2014, 114, 1393–1402. [Google Scholar] [CrossRef] [PubMed]
  34. Kumar, P.; Henikoff, S.; Ng, P.C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 2009, 4, 1073–1081. [Google Scholar] [CrossRef] [PubMed]
  35. Mio, F.; Chiba, K.; Hirose, Y.; Kawaguchi, Y.; Mikami, Y.; Oya, T.; Mori, M.; Kamata, M.; Matsumoto, M.; Ozaki, K.; et al. A functional polymorphism in COL11A1, which encodes the alpha 1 chain of type XI collagen, is associated with susceptibility to lumbar disc herniation. Am. J. Hum. Genet. 2007, 81, 1271–1277. [Google Scholar] [CrossRef] [PubMed]
  36. Maeda, S.; Ishidou, Y.; Koga, H.; Taketomi, E.; Ikari, K.; Komiya, S.; Takeda, J.; Sakou, T.; Inoue, I. Functional impact of human collagen alpha2(XI) gene polymorphism in pathogenesis of ossification of the posterior longitudinal ligament of the spine. J. Bone Min. Res. 2001, 16, 948–957. [Google Scholar] [CrossRef]
  37. Yang, X.; Jia, H.; Xing, W.; Li, F.; Li, M.; Sun, K.; Zhu, Y. Genetic variants in COL11A2 of lumbar disk degeneration among Chinese Han population. Mol. Genet. Genom. Med. 2019, 7, e00524. [Google Scholar] [CrossRef]
  38. Koyama, K.; Nakazato, K.; Min, S.; Gushiken, K.; Hatakeda, Y.; Seo, K.; Hiranuma, K. COL11A1 gene is associated with limbus vertebra in gymnasts. Int. J. Sport. Med. 2012, 33, 586–590. [Google Scholar] [CrossRef]
  39. Jiang, H.; Yang, Q.; Jiang, J.; Zhan, X.; Xiao, Z. Association between COL11A1 (rs1337185) and ADAMTS5 (rs162509) gene polymorphisms and lumbar spine pathologies in Chinese Han population: An observational study. BMJ Open 2017, 7, e015644. [Google Scholar] [CrossRef] [Green Version]
  40. Orozco, G.; Barton, A.; Eyre, S.; Ding, B.; Worthington, J.; Ke, X.; Thomson, W. HLA-DPB1-COL11A2 and three additional xMHC loci are independently associated with RA in a UK cohort. Genes Immun. 2011, 12, 169–175. [Google Scholar] [CrossRef]
  41. Kramer, L.C.; Denegar, C.R.; E Buckley, W.; Hertel, J. Factors associated with anterior cruciate ligament injury: History in female athletes. J. Sport. Med. Phys. Fit. 2007, 47, 446–454. [Google Scholar]
Genes 13 02359 g001 550
Figure 1. The (A) mean ± standard deviation of the active and (B) median (IQRs) of the passive genu recurvatum of the α1(V) (COL5A1), α1(XI) (COL11A1) and α2(XI) (COLL12A1) collagen genotype scores. Participants received a genotype score of 2 for each COL5A1 rs12722 CC, COL11A1 rs3753841 CC, COL11A1 rs1676486 TT and COL12A1 rs1799907 AA genotypes and 0 for all other genotypes, so that the genotype scores ranged from 0 to 8. None of the participants had a genotype score of 8 and the genotype scores of 4 and 6 were combined for the analysis. The individual values are shown as solid grey circles. The global test for linear trend and the Dunn’s multiple comparisons test p values are indicated. Lower degree values for genu recurvatum indicates a greater amount of knee hyperextension.
Figure 1. The (A) mean ± standard deviation of the active and (B) median (IQRs) of the passive genu recurvatum of the α1(V) (COL5A1), α1(XI) (COL11A1) and α2(XI) (COLL12A1) collagen genotype scores. Participants received a genotype score of 2 for each COL5A1 rs12722 CC, COL11A1 rs3753841 CC, COL11A1 rs1676486 TT and COL12A1 rs1799907 AA genotypes and 0 for all other genotypes, so that the genotype scores ranged from 0 to 8. None of the participants had a genotype score of 8 and the genotype scores of 4 and 6 were combined for the analysis. The individual values are shown as solid grey circles. The global test for linear trend and the Dunn’s multiple comparisons test p values are indicated. Lower degree values for genu recurvatum indicates a greater amount of knee hyperextension.
Genes 13 02359 g001
Genes 13 02359 g002 550
Figure 2. The mean ± standard deviation or median (IQRs) of the (A–E) five anterior-posterior laxity and (F–H) three external-internal rotation measurements of the protective α1(V) (COL5A1), α1(XI) (COL11A1) and α2(XI) (COLL12A1) collagen genotype scores. Participants received a genotype score of 2 for each COL5A1 rs12722 CC, COL11A1 rs3753841 CC, COL11A1 rs1676486 TT and COL12A1 rs1799907 AA genotypes and 0 for all other genotypes, so that the genotype scores ranged from 0 to 8. None of the participants had a genotype score of 8 and the genotype scores of 4 and 6 were combined for the analysis. The individual values are shown as solid grey circles.
Figure 2. The mean ± standard deviation or median (IQRs) of the (A–E) five anterior-posterior laxity and (F–H) three external-internal rotation measurements of the protective α1(V) (COL5A1), α1(XI) (COL11A1) and α2(XI) (COLL12A1) collagen genotype scores. Participants received a genotype score of 2 for each COL5A1 rs12722 CC, COL11A1 rs3753841 CC, COL11A1 rs1676486 TT and COL12A1 rs1799907 AA genotypes and 0 for all other genotypes, so that the genotype scores ranged from 0 to 8. None of the participants had a genotype score of 8 and the genotype scores of 4 and 6 were combined for the analysis. The individual values are shown as solid grey circles.
Genes 13 02359 g002
Table
Table 1. Summary of multiple linear regression model for passive genu recurvatum in the non-dominant leg.
Table 1. Summary of multiple linear regression model for passive genu recurvatum in the non-dominant leg.
Passive Genu RecurvatumUnstandardised Coefficient (β)95% CI for βSE βp-Value
Constant175.9167.5 to 184.34.23<0.001
Sex (male)5.002.31 to 7.681.35<0.001
Age (years)0.230.03 to 0.440.100.025
Body Mass (kg)−0.13−0.24 to −0.020.050.018
Genotype Score (2)1.56−0.77 to 3.901.180.187
Genotype Score (4 or 6)3.550.47 to 6.621.550.024
R2 = 0.22 and Adjusted R2 = 0.18
CI = confidence interval; SE β = standard error of the coefficient; R2 = coefficient of determination. Units are shown in parentheses. The α1(V) (COL5A1), α1(XI) (COL11A1) and α2(XI) (COL11A2) collagen genotyping score coding: 0, 2 and 4 or 6. Participants received a genotype score of 2 for the COL5A1 rs12722 CC, COL11A1 rs3753841 CC, COL11A1 rs1676486 TT and/or COL11A1 rs1799907 AA genotypes and 0 for all other genotypes. Genotype scores, therefore, ranged from 0 (none of the injury protective genotypes) to 8 (all four injury protective genotypes). None of the participants had a genotype score of 8. An increase in the measurement of genu recurvatum in degrees indicates decrease in the amount of hyperextension.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Beckley, S.; Dey, R.; Stinton, S.; van der Merwe, W.; Branch, T.; September, A.V.; Posthumus, M.; Collins, M. The Association of Variants within Types V and XI Collagen Genes with Knee Joint Laxity Measurements. Genes 2022, 13, 2359. https://doi.org/10.3390/genes13122359

AMA Style

Beckley S, Dey R, Stinton S, van der Merwe W, Branch T, September AV, Posthumus M, Collins M. The Association of Variants within Types V and XI Collagen Genes with Knee Joint Laxity Measurements. Genes. 2022; 13(12):2359. https://doi.org/10.3390/genes13122359

Chicago/Turabian Style

Beckley, Samantha, Roopam Dey, Shaun Stinton, Willem van der Merwe, Thomas Branch, Alison V. September, Mike Posthumus, and Malcolm Collins. 2022. "The Association of Variants within Types V and XI Collagen Genes with Knee Joint Laxity Measurements" Genes 13, no. 12: 2359. https://doi.org/10.3390/genes13122359

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop